General Information of Drug (ID: DMGNHC2)

Drug Name
MK-3415A Drug Info
Synonyms Actoxumab/bezlotoxumab
Indication
Disease Entry ICD 11 Status REF
Clostridium infection 1A04 Phase 3 [1]
Malaria 1F40-1F45 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMGNHC2

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bezlotoxumab DMTZC5G C. difficile infection 1A04 Approved [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Clostridium difficile Toxin A (CD toxA) TT64H8L TOXA_CLODI Not Available [1]
Clostridium difficile Toxin B (CD toxB) TTQH65V TOXB_CLODI Not Available [1]

References

1 ClinicalTrials.gov (NCT01513239) A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002). U.S. National Institutes of Health.
2 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.